secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zeo ScientifiX, Inc. (ZEOX)
CIK:        0001557376
Form:       8-K
Filed at:   2025-02-10T23:59:59+00:00
Accession:  0001829126-25-000818
Event type: m_and_a
Sentiment:  positive
Materiality: 0.55
Item codes: 1.01, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Zeo ScientifiX enters joint development MOU with BioXtek, appoints Dr. Peter Everts as CSO
--------------------------------------------------------------------------------

- Binding MOU with BioXtek for joint development, manufacturing, marketing, and funding arrangement.
- ZEO to relocate to BioXtek's 11,000 sq ft Pompano Beach facility by May 31, 2025.
- Parties to form 50/50 SPE to pursue FDA BLA approval for membrane products.
- Dr. Peter Everts appointed CSO; salary $220K first year, option for 25,000 shares at $3.05.
- Severance: 1/4 month salary per 3 months after 90-day initial period.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1557376/000182912625000818/0001829126-25-000818-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1557376/000182912625000818/zeoscientifix_8k.htm
  HTML page:      https://secwatch.observer/filing/0001829126-25-000818

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer